Establishing the infrastructure to support personalized medicine, creating a quick development pathway for therapies and improving the medical-device review process are among the major actions the Food and Drug Administration outlined in a new report designed to spur innovation.
FDA seeks to spur innovation
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.